Apologies, been busy, but yes attended an MST sponsored (i think) show and tell. I have some notes which i'll try to share over the next few days, however, MST will most likely have a note on CDX saying the same things.
All very positive, except delay in FDA approval. All the other vitals that will come out with Conneqt is a 1+1=5 scenario. We don't just measure the systolic and diastolic and try to provide health parameters - we also look at the waveform which tells a whole heap more. Which is why the company is able to release a many more bio-markers.
Anyway GLTAH - we're on the right bus.
Add to My Watchlist
What is My Watchlist?
